Poxel has raised €13m ($17m) in a series B round financing to develop and confirm efficacy data of Imeglimin, a drug used to treat type 2 diabetes. Imeglimin is a new tetrahydrotriazine-containing class of oral anti- diabetics, the ...
Tags: Poxel, efficacy data of Imeglimin, drug, ype 2 diabetes
Research and advisory firm, Gartner, has released its list of technology predictions and trends for the years 2013 and beyond. According to Gartner, its top predictions focus on economic risks, opportunities and innovations that will ...
Tags: CIO, Gartner, IT, predictions, research, technology
Philosys is looking forward for the US Food and Drug Administration (FDA) approval of its new Gmate blood glucose monitoring system in third quarter 2012. By utilizing Smartphone technology, Gmate blood glucose meter works with the ...
Tags: Philosys, FDA approval, blood glucose monitoring system
Philosys, a contract design, development and manufacturing company, has obtained CE mark approval for its new Gmate SMART blood glucose monitor. By using the operating system of the smart phone, the patent pending technology of the Gmate ...
Tags: Philosys, Gmate SMART blood glucose monitor, Gmate SMART
Covidien has reported final 12-month results from Determination of Effectiveness of SilverHawk / TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities (DEFINITIVE LE ) trial. The ...
Tags: Covidien, 12-month results, DEFINITIVE LE trial, prospective study
Diagnos has initiated a new screening program for the prevention of diabetic retinopathy and vision loss in Canada. Under the new 'BEAT IT IN A BLINK' program, the company will make use of its proprietary Computer Assisted Retinal ...
Tags: Diagnos, screening program, diabetic retinopathy, vision loss
Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in adults, in India. Linagliptin, which is approved in the US, the European Union, Japan and ...
Tags: Diabetes Drug, product of Boehringer, diabetes epidemic
Medi+Sure, a provider of diabetes devices, has announced that the Government of British Columbia (BC) has approved its 49c Medi+Sure blood glucose test strips. The approval allows Medi+Sure to provide its Medi+Sure blood glucose test ...
Life-enhancing innovations to help people with visual impairments to navigate the internet,wheelchair users to negotiate the urban environment,autistic children to communicate and diabetics to manage their condition,were among the ...
Tags: Helen Hamlyn Design Awards, Age UK, Technology Strategy Board